Hostname: page-component-848d4c4894-mwx4w Total loading time: 0 Render date: 2024-06-25T07:29:22.805Z Has data issue: false hasContentIssue false
  • English
  • Français

Human papillomavirus 16 and p16 positive nasal cutaneous squamous cell carcinoma in immunocompetent men in their twenties

Published online by Cambridge University Press:  10 April 2019

N Amiraraghi ,
R A Scott ,
N Balaji  and
M M C Yaneza
N Amiraraghi*
Affiliation:
ENT Department, University Hospital Monklands, Airdrie, Scotland, UK
R A Scott
Affiliation:
ENT Department, University Hospital Monklands, Airdrie, Scotland, UK
N Balaji
Affiliation:
ENT Department, University Hospital Monklands, Airdrie, Scotland, UK
M M C Yaneza
Affiliation:
ENT Department, University Hospital Monklands, Airdrie, Scotland, UK
*
Author for correspondence: Miss Natasha Amiraraghi, C/O Miss May Yaneza, ENT Department, University Hospital Monklands, Monkscourt Avenue, Airdrie ML6 0JS, Scotland, UK E-mail: Natasha.amiraraghi@nhs.net
Get access Rights & Permissions [Opens in a new window]

Abstract

Background

Cutaneous squamous cell carcinoma is usually associated with long-term ultraviolet light exposure. Human papillomavirus 16 is a high-risk mucosal human papillomavirus type, usually associated with anogenital and oropharyngeal cancer. This paper describes the first two cases of human papillomavirus 16 and p16 related nasal cutaneous squamous cell carcinoma.

Method

Prospective case series from December 2015.

Results

Two young, male, fair-skinned patients had large (greater than 20 mm), rapidly growing, ulcerated lesions of the nasal tip. The tumours were excised, with at least a 6 mm margin, and the patients' noses were subsequently reconstructed. Neither patient had cervical lymphadenopathy or underwent adjuvant radiotherapy. Both patients were registered at the same general practice. The tumours were human papillomavirus 16 and p16 positive; the latter indicated that the virus was driving the disease process. Except for superficial burns, neither patient had other risk factors.

Conclusion

Changes in sexual practices have led to an increase in human papillomavirus positive oropharyngeal carcinoma and there may be an associated increase in human papillomavirus type 16 positive nasal cutaneous squamous cell carcinoma.

Keywords

PapillomaviridaeNoseCarcinomaSquamous Cell
Type
Clinical Record
Information
The Journal of Laryngology & Otology , Volume 133 , Issue 4 , April 2019 , pp. 348 - 352
Copyright
Copyright © JLO (1984) Limited, 2019 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

Miss N Amiraraghi takes responsibility for the integrity of the content of the paper

References

1Gavioli, CFB, Festa, NC, Tyring, SK, Silva, LL da C, Oliveira, WRP de. High-risk mucosal HPV types associated with squamous cell carcinoma on the nose tip in an immunocompetent young man. An Bras Dermatol 2018;93:716–18Google Scholar
2Stanley, RJ, Olsen, KD. Rhinectomy for malignant disease. A 20-year experience. Arch Otolaryngol Head Neck Surg 1988;114:1307–11Google Scholar
3Li, W, Thompson, CH, O'Brien, CJ, McNeil, EB, Scolyer, RA, Cossart, YE et al. Human papillomavirus positivity predicts favourable outcome for squamous carcinoma of the tonsil. Int J Cancer 2003;106:553–8Google Scholar
4Extending the HPV vaccination programme: JCVI statement. In: https://www.gov.uk/government/publications/jcvi-statement-extending-the-hpv-vaccination-programme [19 July 2018]Google Scholar
5O'Sullivan, B, Huang, SH, Su, J, Garden, AS, Sturgis, EM, Dahlstrom, K et al. Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): a multicentre cohort study. Lancet Oncol 2016;17:440–51Google Scholar
6Harwood, CA, McGregor, JM, Proby, CM, Breuer, J. Human papillomavirus and the development of non-melanoma skin cancer. J Clin Pathol 1999;52:249–53Google Scholar
7Harwood, CA, Surentheran, T, McGregor, JM, Spink, PJ, Leigh, IM, Breuer, J et al. Human papillomavirus infection and non-melanoma skin cancer in immunosuppressed and immunocompetent individuals. J Med Virol 2000;61:289–97Google Scholar
8Newlands, C, Currie, R, Memon, A, Whitaker, S, Woolford, T. Non-melanoma skin cancer: UK National Multidisciplinary Guidelines. J Laryngol Otol 2016;130(suppl 52):125–32Google Scholar
9Centers for Disease Control and Prevention (CDC). Human papillomavirus-associated cancers - United States, 2004–2008. MMWR Morb Mortal Wkly Rep 2012;61:258–61Google Scholar
10Extending the HPV vaccination programme: JCVI statement. In: https://www.gov.uk/government/publications/jcvi-statement-extending-the-hpv-vaccination-programme [19 July 2017]Google Scholar
11Mercer, CH, Tanton, C, Prah, P, Erens, B, Sonnenberg, P, Clifton, S et al. Changes in sexual attitudes and lifestyles in Britain through the life course and over time: findings from the National Surveys of Sexual Attitudes and Lifestyles (Natsal). Lancet 2013;382:1781–94Google Scholar
12Hughes, G, Field, N. The epidemiology of sexually transmitted infections in the UK: impact of behaviour, services and interventions. Future Microbiol 2015;10:35–51Google Scholar